These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15359788)

  • 1. [Th1/Th2 balance in HCV-related liver cirrhosis and the effect of TGF-beta on Th1 response: possible implications for the development of hepatoma].
    Sakaguchi E; Sakaida I; Okita K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):175-8. PubMed ID: 15359788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Th1/Th2 imbalance in HCV-related liver cirrhosis].
    Sakaguchi E; Kayano K; Segawa M; Aoyagi M; Sakaida I; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1259-63. PubMed ID: 11494534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
    Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):959-63. PubMed ID: 18259753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine circuits in tuberculosis.
    Toossi Z
    Infect Agents Dis; 1996 Mar; 5(2):98-107. PubMed ID: 8721046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of immune function in liver cirrhosis patients after splenectomy combined with resection of hepatocellular carcinoma].
    Cao Z; Cheng X; Wu Z
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):97-9. PubMed ID: 11955389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
    Momiyama K; Nagai H; Sumino Y
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):271-7. PubMed ID: 19011857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis.
    Kogame M; Nagai H; Shinohara M; Igarashi Y; Sumino Y; Ishii K
    Anticancer Res; 2016 Sep; 36(9):4529-36. PubMed ID: 27630292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
    Mahendra A; Misra R; Aggarwal A
    J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
    Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
    Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th2 lymphocyte balance in patients with aplastic anemia.
    Kaito K; Otsubo H; Usui N; Kobayashi M
    Rinsho Byori; 2004 Jul; 52(7):569-73. PubMed ID: 15344555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA; Xu H; Fairchild RL
    Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10.
    von der Weid T; Bulliard C; Schiffrin EJ
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):695-701. PubMed ID: 11427413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12.
    Lingnau K; Hoehn P; Kerdine S; Koelsch S; Neudoerfl C; Palm N; Ruede E; Schmitt E
    J Immunol; 1998 Nov; 161(9):4709-18. PubMed ID: 9794401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues.
    Qiu FB; Wu LQ; Lu Y; Zhang S; Zhang BY
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):63-6. PubMed ID: 17287169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
    Kamar N; Rostaing L; Sandres-Saune K; Selves J; Barthe C; Dubois M; Alric L; Durand D; Izopet J
    J Med Virol; 2005 Aug; 76(4):482-8. PubMed ID: 15977245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology.
    Nagai H; Mukozu T; Kobayashi K; Amanuma M; Yoshimine N; Ogino YU; Matsui D; Daido Y; Matsukiyo Y; Matsui T; Wakui N; Momiyama K; Shinohara M; Higai K; Igarashi Y
    Anticancer Res; 2019 Apr; 39(4):2183-2191. PubMed ID: 30952766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.